Showing results (111-120 of 279) with videos related to

Sort By:
Pageof 28
Pediatric Blood & Cancer|December 19, 2018
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000Angela Schumich, Margarita Maurer-Granofszky, Andishe Attarbaschi, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing DataGudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel, et al.
Blood|June 19, 2009
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocolsMartin Stanulla, Elke Schaeffeler, Anja Möricke, et al.
Pediatric Blood & Cancer|April 4, 2017
Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhoodJuliane Schmäh, Birthe Fedders, Renate Panzer-Grümayer, et al.
Blood|July 13, 2017
An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenograftsDenis M Schewe, Ameera Alsadeq, Cornelia Sattler, et al.
Lancet (London, England)|August 23, 2005
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective studyAdriana Balduzzi, Maria Grazia Valsecchi, Cornelio Uderzo, et al.
Blood|June 15, 2011
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartmentMaike Schmitz, Petra Breithaupt, Nastassja Scheidegger, et al.
Genes, Chromosomes & Cancer|August 30, 2021
Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencingMustafa Salim, Frederik Heldt, Kathrin Thomay, et al.
BMC Cancer|June 20, 2018
MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κBDavid M Cordas Dos Santos, Juliane Eilers, Alfonso Sosa Vizcaino, et al.
Blood|May 3, 2007
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemiaJames B Nachman, Nyla A Heerema, Harland Sather, et al.
Pageof 28